CP-316819 is a potent glycogen phosphorylase (GPase) inhibitor with hypoglycemic activity; it promotes glycogen accumulation under normoglycemic conditions while allowing glycogen utilization under low glucose conditions; it prevents neuronal cell death and maintains cerebral electrical activity.